APH

Amphenol Corporation

NYSE • USD • TECHNOLOGY • HARDWARE, EQUIPMENT & PARTS

Current Price $141.03 3 Months: +8.48%

52-Week Range

$79.10 $167.04

Current price is 70.4% of 52-week range

Key Metrics

Market Cap $174.9B
P/E Ratio N/A
Current Ratio N/A
EPS
Dividend Yield N/A
ATR(14) $5.77
Beta 1.3
PEG Ratio N/A
ROE N/A
Operating Earnings Growth Rate N/A

AI Overview

Last updated 7 days ago

Amphenol is a global scale leader in connectors and interconnect/sensor components, selling into diversified end markets (IT/data communications, communications networks, industrial, auto, defense/aerospace), which helps smooth single-cycle downturns and sustains pricing power. Its long record of bolt-on M&A is a real advantage in a fragmented supply chain, expanding product breadth and customer content per platform. The key industry tailwinds remain electrification, higher data center connectivity density, and increased sensorization across vehicles and industrial automation.

Fundamentals exiting 2025 were exceptionally strong: Q4 2025 sales were $6.4B and adjusted EPS was $0.97, while full-year 2025 GAAP EPS was $3.34. Management also disclosed that its CCS business is expected to contribute roughly $4.1B of 2026 sales and about $0.15 to 2026 adjusted diluted EPS, reinforcing that growth is not purely cyclical. Valuation looks demanding: the stock has recently screened around the low-40s trailing P/E and roughly mid-30s forward P/E by third-party estimates, leaving less room for execution errors, even with a modest dividend (commonly shown near ~$1.00 annualized).

My 12-month thesis is that APH can still compound, but returns are likely to track earnings more than multiple expansion from here; the stock needs continued organic growth plus clean integration to justify the premium. Catalysts include sustained AI/data center interconnect demand, incremental upside from CCS cross-selling, and another year of strong EPS conversion. Key risks are integration/margin slippage from heavy acquisition activity, a sharper industrial/auto slowdown, and any reset in investor willingness to pay premium multiples for “quality compounders.”

Recommendation: HOLD. The business quality and earnings momentum are attractive, but the current valuation appears to already discount a lot of the acquisition-driven growth and leaves limited margin of safety if growth normalizes.

Price & Profitability History

3 Months change: +8.48% (+$11.03)

Log in